PROGRAMthyroidworldcongress.com/.../2017/07/WCTC2017_Program-FINAL-PROOF.pdfappointed the Jay L....

JULY 27 - 30, 2017 | The Westin Boston Waterfront

PROGRAM3RD WORLD CONGRESS ON THYROID CANCER

thyroidworldcongress.com

World Congress on Thyroid Cancer2

Welcome Letter from Steering Committee

Dear Colleagues and Guests:

On behalf of the entire Steering Committee, it gives us great pleasure

to welcome you to Boston and to the Third World Congress on Thyroid Cancer.

With registration approaching 1200 Professionals, WCTC-3 is the largest meeting in the World

dedicated to Thyroid Nodules and Thyroid Cancer. And with participation from 72 countries and almost

every continent, WCTC-3 is the most diverse and most broadly representative such meeting ever held.

Uniquely, WCTC at its core is a multidisciplinary international Congress engaging equally Attendees

with a broad range of backgrounds, education, specialty affiliation, and expertise, including Surgeons,

Endocrinologists, Medical and Radiation Oncologists, Pathologists, Radiologists, Physician Assistants

and Nurse Practitioners, Geneticists, Scientists and Nuclear Medicine specialists. WCTC-3 is endorsed

by more 60 national and international professional societies and patient advocacy groups including

the American Head and Neck Society Endocrine Section, the International Association of Endocrine

Surgery, the American Thyroid Association, the American Association of Clinical Endocrinologists and

ThyCa to name a few. WCTC-3 offers unique opportunities for networking and learning from the

experience of colleagues the world over.

Our Keynote Speakers are world-renowned experts in their field. Our Panel Moderators and Panelists

represent the best and brightest multidisciplinary faculty in the world. Our Instructional Course and

Meet the Professor sessions are populated with International, National and Regional specialists with

deep clinical and scientific insight. And, of course, you – our Attendees – are the most important voices

at this Congress. It is your participation and engagement that distinguishes the World Congress from

almost any other meeting in this field. It is your interest and enthusiasm that challenges these experts

to question their assumptions, to break new ground and to help us build an evidence-based, outcomes

oriented, cost-effective, personalized, compassionate approach to patients with thyroid tumors.

We also acknowledge and thank our Industry Sponsors and Exhibitors, without whose support we

could not hold this meeting. We recognize their critical role in some of the most exciting recent

advances in our field: improved imaging, molecular markers, clinical trials of Tyrosine Kinase Inhibitors,

novel surgical technologies, better complication management and many other areas.

The first two iterations of the World Congress on Thyroid Cancer were acclaimed as “amongst the best

thyroid cancer meetings in the World”. We believe that WCTC-3 will prove to be even more effective,

providing a unique venue to define current best practice, to advance the science, and to nurture the

friendships and professional relationships critical to advancing the care of patients with Thyroid Cancer.

Start planning now for WCTC 4.0, to be held again in Boston in the summer of 2021. Also, watch out for

news of an interval Congress – WCTC 3.5 – planned for 2019 in a location yet to be announced!

Welcome to Boston

Welcome to the World Congress

And welcome to the future of Thyroid Cancer!

3

Dr. Keith D. Lillemoe received his undergraduate education at the University of South Dakota and his MD from The Johns Hopkins University School of Medicine in l978. He served his entire surgical training at The Johns Hopkins Hospital from l978 to l985. He joined the faculty at Hopkins in l985 and rose to the rank of Professor of Surgery in l996. He served as Associate Program Director for the Hopkins Surgical Residency from l993 to 2003 and Vice-Chairman and Deputy Director of the department from l997 to 2003. In September 2003 he was appointed the Jay L. Grosfeld Professor and Chairman of the Department of Surgery at the Indiana University School of Medicine. He also served as the Program Director of their general surgery residency. In May 2011, Dr. Lillemoe was appointed to the position of Surgeon-in-Chief and Chief of the Department of Surgery at the Massachusetts General Hospital in Boston and the W. Gerald Austen Professor of Surgery at the Harvard Medical School.

Dr. Lillemoe is a member of most surgical societies and has held office in many. He has served as Secretary, President and Chairman of the Board of Trustees of the Society for Surgery of the Alimentary Tract. He has previously served as President of the Society of Clinical Surgery, Secretary and President of the Society of University Surgeons, and President of the Halsted Society. He has served as the Recorder and is the immediate past President of the American Surgical Association. Dr. Lillemoe is a Senior Director of the American Board of Surgery. In April of 2015 Dr. Lillemoe was inducted into the Johns Hopkins Society of Scholars.

Dr. Welling currently is the Walter Augustus LeCompte Professor and Chair of the Harvard Department of Otolaryngology and is the Chief of Otolaryngology at Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital. He received his undergraduate Bachelor of Arts in Chemistry, with a minor in Japanese, from the University of Utah where he also received his MD degree. His Otolaryngology Head and Neck Surgery residency was completed at the University of Iowa in Iowa City, Iowa and his fellowship in Otology, Neurotology, and Cranial Base Surgery was completed with Michael Glasscock, III at the EAR Foundation in Nashville, Tennessee. After joining the faculty at The Ohio State University, he completed a PhD in pathobiology and was recently granted an Honorary Masters of Science from Harvard University.

Previously Dr. Welling chaired the Department of Otolaryngology at The Ohio State University, served as Vice President of the Triological Society, president of the American Neurotology Society and president of the American Otological Society. He is US President of the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum (CORLAS). He is a member of the Board of Directors of the American Board of Otolaryngology and is a member of the Residency Review Committee of the Accreditation Council on Graduate Medical Education (ACGME). He has published over 100 manuscripts in peer-reviewed journals and is currently the Editor-in-Chief of the Laryngoscope Investigative Otolaryngology journal.

Josh Zakim was elected to the Boston City Council on November 5, 2013. Josh represents District 8, which includes the neighborhoods of the Back Bay, Beacon Hill, Fenway, Kenmore Square, Mission Hill, and the West End.

A progressive voice in Boston’s City Council, Josh has proven to be a strong advocate for issues of social and economic justice. He chairs the City Council’s Committee on Housing and Community Development and the Special Committee on Civil Rights. Josh continues to advocate for policies that make Boston a welcoming city, including improving access to Boston’s public schools, creating and maintaining affordable housing, and advocating for the rights of the working class, immigrant families, and the LGBTQ community.

Before running to serve on the Boston City Council, Josh worked as an attorney at Greater Boston Legal Services and then at the law firm Mintz Levin. In addition to his role on the City Council, Josh continues to be an active Board Member of the Lenny Zakim Fund, an organization founded by his later father and friends that supports innovative, grassroots organizations dedicated to tackling complex social issues.

D. Bradley Welling, M.D., Ph.D.,FACSWalter Augustus LeCompte ChairHarvard Department of OtolaryngologyChief Otolaryngology Massachusetts Eye and EarChief Otolaryngology Massachusetts General Hospital

Keith D. Lillemoe, M.D.Surgeon-in-ChiefChief of SurgeryMassachusetts General HospitalW. Gerald Austen Professor of SurgeryHarvard Medical School

Councillor Josh Zakim City of Boston

Welcome Remarks from Boston


TABLE OF CONTENTS2 LETTER OF WELCOME

3 WELCOME REMARKS FROM BOSTON

5 STEERING COMMITTEE

6 SCIENTIFIC FACULTY

7 SUPPORTING ORGANIZATIONS

8 WCTC INDUSTRY PARTNERS

9 EXHIBIT HALL

9 PRODUCT THEATER

10 MAP OF THE HOTEL

12 INFORMATION

13 PROGRAM AT A GLANCE

14 THURSDAY, JULY 27, 2017

15 FRIDAY, JULY 28, 2017

17 SATURDAY, JULY 29, 2017

19 SUNDAY, JULY 20, 2017

20 KEYNOTE SPEAKERS

22 SPONSORED SYMPOSIA

24 PANEL SESSIONS

25 MEET THE PROFESSOR

27 INSTRUCTIONAL COURSES

30 ORAL PAPER SESSIONS

31 VIDEO SESSIONS

32 ePOSTERS

5

The Steering Committee

Jeremy Freeman, MD University of Toronto

Gregory W. Randolph, MD, FACS, FACE Harvard Medical SchoolCo-Chair

Ashok R. Shaha, MD Memorial Sloan–Kettering Cancer Center

Bryan Haugen, MD University of Colorado

Bryan McIver, MD, PhD, FRCP (Edin) Moffitt Cancer CenterCo-Chair

Steven I. Sherman, MD The University of Texas MD Anderson Cancer Center

Jatin P. Shah, MD Cornell Memorial Sloan -Kettering Cancer Center

Ezra Cohen, MD Moores Cancer Center

Ian Witterick, MDUniversity of Toronto

World Congress on Thyroid Cancer Secretariat: The Bayley Group

bayleygroup.com


Scientific FacultyName Country

Gaurav Agarwal IndiaAmit Agarwal IndiaKenneth Ain USAErik Alexander USAPeter Angelos USAAngkoon Anuwong ThailandAnca Avram USAJung Hwan Baek KoreaC.S. Bal IndiaZubair Baloch USARonald Balassanian USADaniele Barbaro ItalyMarcin Barczynski USAAndrew Bauer USAVictor Bernet USAKeith Bible USALaura Boucai USADaniel Branovan USAJim Brierley CanadaMarcia Brose USAKevin Brumund USAKen Burman USANaifa Busaidy USAMaria Cabanillas USAClaudio Cernea BrazilAmy Chen USAEdmund Cibas USAJonathan Clark AustraliaGary Clayman USAEzra Cohen USADavid Scott Coombes WalesGilbert Cote USAMichele d’Ajello ItalyLouise Davies USAGillian Diercks USAGianlorenzo Dionigi ItalyGerard Doherty USAHenning Dralle GermanyQuan-Yang Duh USAManuel Durán SpainCosimo Durante ItalyMete Düren TurkeyBeth Edeiken-Monroe USALeslie Eldeiry USARossella Elisei ItalyGuido Fadda ItalyJames Fagin USATom Fahey USAWilliam Faquin USARobert Ferris USASebastiano Filetti ItalyStephanie Fish USADan Fliss IsraelAndrea Frasoldati ItalyMary Frates USAJeremy Freeman CanadaNobuhiro Fukunari JapanIan Ganly USAJeff Garber USARonald Ghossein USARalph Gilbert CanadaOliver Gimm SwedenHernán González Chile

Name Country

Peter Goretzki GermanyRavinder Grewal USARaymon Grogan USAElizabeth Grubbs USAPatrick Gullane CanadaMack Harrell USADana Hartl USABryan Haugen USAIan Hay USAMegan Rist Haymart USAJames Hennessey USATara Henrichsen USAMiguel Herrera MexicoSteven Hodak USARichard Hodin USAYariv Houvras USAJonathan Irish CanadaYasuhiro Ito JapanKwang Yoon Jung KoreaEmad Kandil USAGiulia Kennedy USASaad Khan USAHoon Yub Kim KoreaMatthew Kim USAYoon Woo Koh KoreaPeter Kopp USADennis Kraus USATeresa Kroeker USASophie Leboulleux FranceGeeta Lal USAStephanie Lee USARobert Levine USASteve Libutti USADerrick Lin USAVirginia LiVolsi USARicardo Lloyd USALaurie Loevner USACelestino Lombardi ItalyJochen Lorch USACarrie Lubitz USAMark Lupo USAMarkus Luster GermanyChristina Macmillan CanadaMatthew Magarey AustraliaUjjal Mallick UKSusan Mandel ItalyEllen Marqusee USABryan McIver USAPaolo Miccoli ItalyAkira Miyauchi JapanJeff Moley USAEleonora Molinaro ItalyLuc Morris USAKate Newbold UKYuri Nikiforov USAPieter Noordzij USAVânia Nosé USAMichael Odell CanadaTakahiro Okamoto JapanLisa Orloff USACarsten Palme AustraliaSareh Parangi USAKepal Patel USARichard Payne Canada

Name Country

Elizabeth Pearce USAPhilip Pelliterri USANancy Perrier USAFabian Pitoia ArgentinaGregory Randolph USAMatthew Ringel USASara Rosenthal USADoug Ross USAMona Sabra USAWendy Sacks USAPeter Sadow USAGuri Sandhu UKAnna Sawka CanadaJoseph Scharpf USAMartin Schlumberger FranceJatin Shah USAAshok Shaha USARicard Simo UKCatherine Sinclair USAMichael Singer USARobert Smallridge USAJohannes Smit NetherlandsRussell Smith USACarmen Solórzano USAJulie Ann Sosa USABrendan Stack USANikolas Stathatos USAAntonia Stephen USADavid Steward USAAntonio Stiges-Serra SpainIwao Sugitani JapanHyun Suh USAShinichi Suzuki JapanKyung Tae KoreaHiroshi Takami JapanDavid Terris USAGeraldine Thomas UKGeoffrey Thompson USANeil Tolley UKRichard Tsang CanadaRalph Tufano USAMichael Tuttle USAMark Urken USAPablo Valderrabano USADouglas VanNostrand USAMark Varvares USAErivelto Volpi BrazilSteven Waguespack USACheng-ping Wang TaiwanLeonard Wartofsky USABruce Wenig USALori Wirth USARobert Witt USAIan Witterick CanadaRich Wong USAChe-Wei Wu TaiwanMingzhao Xing USAWoong Youn Chung KoreaEugene Yu CanadaMark Zafereo USAPat Zanzonico USAMartha Zeiger USADonald Zimmerman USA

7

Supporting Organizations

American Association of Endocrine Surgeons (AAES)

American Association of Clinical Endocrinologists (AACE)

American Head and Neck Society (AHNS)

Annals of Thyroid (AOT)

American Thyroid Association (ATA)

Asian and Oceania Thyroid Association (AOTA)

Asia-Oceania Association of Otolaryngology Societies

Asian Society of Head & Neck Oncology

Asia-Pacific Society of Thyroid Surgery

Asociación Argentina de Cirugía de Cabeza y Cuello (AACCyC)

Association Vivre sans Thyroïde (France)

Association of Women Surgeons (AWS)

Australian and New Zealand Endocrine Surgeons (ANZES)

Australian Society of Otolaryngology Head & Neck Surgery (ASOHNS)

Brazilian Society of Head and Neck Surgery

Belgian Head & Neck Oncology Cooperative Group

British Association of Head and Neck Oncology (BAHNO)

British Thyroid Association

Canadian Association of Pathologists (CAP)

Canadian Society of Endocrinology and Metabolism

Canadian Society of Otolaringology – Head and Neck Surgery

Cirendocrin

Dutch Endocrine Society

Endocrine Society

European Laryngological Society (ELSOC)

European Society of Endocrinology (ESE)

Foundation for Head and Neck Oncology

French Endocrine Society (Société Française d’Endocrinologie – SFE)

Georgian Union of Diabetes and Endocrine Associations (GUDEAS)

German Society of ORL HNS

German Thyroid Cancer Survivors’ Association

International Association of Endocrine Surgeons (IAES)

International Federation of Head and Neck Oncologic Societies (IFHNOS)

International Federation of Oto-Rhino-Laryngological Societies (IFOS)

International Thyroid Oncology Group (ITOG)

Israel Endocrine Society

Italian Endocrine Society (Società Italiana di Endocrinologia – SIE)

Italian Head and Neck Society

Journal of Cancer Metastasis and Treatment (JCMT)

Korean Association of Thyroid and Endocrine Surgeons (KATES)

Korean Society for Head and Neck Oncology (KSHNO)

Korean Society of Thyroid-Head and Neck Surgery (KSTHNS)

Korean Society of Otorhinolaryngology-Head and Neck Surgery

Korean Thyroid Association (Multidisciplinary Society)

Latin American Thyroid Society (LATS)

Bundesverband Schilddrüsenkrebs – Ohne Schilddrüsen leben e.V

Polish Study Group of Head and Neck Cancer

Royal College of Surgeons of Edinburgh

Scandinavian Society for Head and Neck Oncology (SSHNO)

Sköldkörtelförening Sverig (Swedish Thyroid Association)

Sociedad Chilena de Cirugia Cabeza-Cuello Y Plastico Maxilo Facial (SCCCCPMF)

Society of Nuclear Medicine and Molecular Imaging

The Israel Society of Head and Neck Surgery and Oncology

The Japan Endocrine Society

The Japan Thyroid Association

The New Zealand Society of Otolaryngology, Head & Neck Surgery (NZSOHNS)

ThyCa: Thyroid Cancer Survivors’ Association, Inc.

Thyroid Cancer Alliance

Thyroid Federation International


WCTC Industry Partners

The WCTC3 Steering Committee gratefully acknowledges the financial contribution

from the following companies:

D I A G N O S T I C S

TM

Legally Mine

Thank you to our Faculty Sponsor for sponsoring Dr. Anca Avram and Dr. Douglas VanNostrand!

9

American Association of Clinical Endocrinologists

American Thyroid Association

Bioscientifica

CBL Path

Checkpoint Surgical

Domain Surgical

Exelixis, Inc.

Elsevier Medical Publishers

Eisai, Inc.

Ethicon

Geneprodx

Genzyme

Interpace Diagnostics

Invuity

Legally Mine

Light of Life Foundation

Medtronic

Olympus America Inc.

Quest Diagnostics

RF Medical Co. Ltd.

Rosetta Genomics

Sanofi Genzyme

Shire

STARmed

Stryker

ThyCa – Thyroid Cancer Survivors Association Inc.

Thyroid Cancer Alliance

Thyroid Care Collaborative (TCC)

Veracyte

Zero Gravity Skin

EXHIBIT HALL GALLERIA, HARBORWING CONCOURSE LEVEL

FRIDAY, JULY 28, 2017

TIME PRESENTATION SPEAKER(S): SPONSORED BY

12:30 pm – 1:30 pm

Medullary Thyroid Cancer: A Multidisciplinary Approach to Treatments Bryan McIver Sanofi Genzyme

6:30 pm – 7:30 pm

Recurrent Laryngeal Nerve Monitoring as a Standard of Care – standards, technology, and implementation

Christoph Ulmer Stryker

SATURDAY, JULY 29 , 2017

12:30 pm – 1:30pm

CBLPath/UPMC Expo Theater: Clinical Utility of ThyroSeq for Thyroid Nodules

Yuri Nikiforov Steven Hodak Stephanie Lee Kristen Otto

CBL Path

2:00 pm – 3:00pm

Understanding Legal Tools: The Keys to Locking out Lawsuits and Lowering Taxes This presentation is designed for Practicing US Physicians.

Art McOmbre Legally Mine

Product Theater EXHIBIT HALLGALLLERIA


WESTIN FLOOR PLANS

HARBORWING, CONCOURSE LEVEL

GALLERIAEXHIBIT HALL

LEFT SIDE OF LOBBY ESCALATOR DOWN ONE LEVEL

BURROUGHS

CARLTON

HARBORWING, CONFERENCE LEVEL

LEWIS

GRIFFIN

Escalator to and�from Lobby Level �(right side)

Escalator to and�from Lobby Level �

(right side)

RIGHT SIDE OF LOBBY ESCALATOR UP ONE LEVEL

LunchesePostersBreaks

Product Theater

11

LOBBY LEVEL

HANCOCK

PAINE

QUINCY

MAIN ENTRANCE

CONFERENCEREGISTRATION

HOTEL CHECK-IN

SYMPOSIA

REVERESTONE

WEBSTER

MARINA BALLROOM

MAIN LEVEL / GROUND FLOOR

Escalator down one level to Concourse Level

Escalator down one level to Harborwing

Concourse Level

Escalator to Lobby Level

GRAND BALLROOM

COMMONWEALTH BALLROOM

CONCOURSE LEVEL

RIGHT SIDE LOBBY OF ESCALATOR DOWN ONE LEVEL

KeynotesPlenaries


INFORMATIONCOMPLIMENTARY WI-FI FOR DELEGATES Westin Boston Meetings Password: WCTC2017

CELL PHONES & E–DEVICES As a courtesy to your fellow delegates and speakers, please remember to turn “OFF” cell phones while in the education sessions.

NAME BADGESIt is imperative to wear your name badge at all times during the conference. It will provide access to the sessions and social events.

EVALUATIONS An evaluation survey will be sent to each delegate via email at the conclusion of the World Congress on Thyroid Cancer.

CMEThe University of Colorado School of Medicine designates the 3rd World Congress on Thyroid Cancer for a maximum of 23.5 AMA PRA Category 1 Credit(s) TM for the main conference. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

REGISTRATION DESK HOURS - Grand Ballroom Foyer

Thursday 3:00 pm – 7:00 pmFriday 7:00 am – 5:00 pmSaturday 7:00 am – 5:00 pmSunday 7:00 am – 11:00 am

EXHIBIT HALL HOURS - Galleria

Friday 10:00 am – 4:00 pmSaturday 10:00 am – 4:00 pm

WCTC APPIncrease your engagement and don’t miss a thing! Download and stay up to date with programing and events: https://goo.gl/WLfNLJ

Password: WCTC2017

CONGRESS RECEPTION - Galleria

Friday, July 29, 2017, 6:00 pm – 8:00 pm

CONGRESS BANQUET - Grand Ballroom

Saturday, July 30, 2017, 7:30 pm – 10:00 pm

DINNER SYMPOSIUM - Marina Ballroom (No CME)

Thursday, July 28, 2017 7:00 pm

Why and How I Use Nerve Monitoring : Perspectives from Around the World Sponsored by Medtronic

BREAKFAST SYMPOSIA - Marina Ballroom (No CME)Each morning 6:00 am – 7:30 am

Friday, July 28, 2017

Diagnosis & Management of Advanced Thyroid Cancer Sponsored by Eisai

Saturday, July 29, 2017

Importance of a Personalized Approach in the Risk Stratification of Patients with DTC Sponsored by Sanofi Genzyme

Sunday, July 30, 2017

The New Afirma Genomic Sequencing Classifier – Leveraging Enriched Genomic Data through RNA Sequencing and Advancements in Machine Learning to Identify More Benign Thyroid Nodules Sponsored by Veracyte

*NOTE • all Sponsored Symposiums will be in Marina Ballroom• all Keynotes & Panels will be in the Grand Ballroom • Refreshment Breaks, Lunch & Exhibits will be in Galleria

WCTC 5K WALK OR RUN - Shuttles Provided

Sunday, July 30, 2017 6:00 am – 7:45 am

Registrations accepted during the Congress in Exhibit HallSponsored by Sanofi Genzyme

FOR MEDICAL OR SECURITY EMERGENCIESOn a house phone, dial “O” for the operator or Ext. #4898 for security For serious medical or security emergencies - dial “911” on your phone

13

Program at a Glance

TIME THURSDAY JULY 27, 2017 FRIDAY JULY 28, 2017 SATURDAY JULY 29, 2017 SUNDAY JULY 30, 2017

OPEN - 3:00 - 7:00 pm OPEN - 7:00 - 5:00 pm OPEN - 7:00 - 5:00 pm OPEN - 7:00 - 11:00 am

6:00 6:00 - 7:30Breakfast Symposium

Sponsored by Eisai (No CME)

6:00 - 7:30Breakfast Symposium

Sponsored by Sanofi Genzyme(No CME)

6:00 - 7:30Breakfast

Symposium Sponsored by

Veracyte (No CME)

6:00 - 7:45WCTC 5K Run

& Walk Sponsored by

Sanofi Genzyme

7:00 7:00 - 8:00 Coffee, Tea and Juice will be served

7:40 7:40 - 8:00 Welcome Remarks

7:40 - 8:00 Morning Remarks

7:40 - 8:00 Morning Remarks

8:00 8:00 - 4:30 Ultrasound Basic

8:00 - 5:00 Ultrasound Advanced

8:00 - 9:30 Panel 1

Oral Papers - 1 & 2

8:00 - 9:30 Panel 5

Oral Papers - 5 & 6

8:00 - 9:30

Panel 8 Oral Papers - 11 - 14

9:30 9:30 - 10:00 Keynote Lecture 1

9:30 - 10:00 Keynote Lecture 4

9:30 - 10:30

Hot Topic 3 NIFTP and Bethesda 2

10:00 10:00 - 10:30 BREAK / Exhibit Hall

10:00 - 10:30 BREAK / Exhibit Hall

10:30 10:30 - 12:00 Panel 2

Oral Papers - 3 & 4

10:30 - 12:00 Panel 6

Oral Papers - 7 & 8

10:30 - 12:00 Conversation with the Masters

12:00 PRE-CONGRESS SYMPOSIA

12:00 - 3:00 Latin America

12:00 - 3:00 Asia Pacific

12:00 - 3:00 Indian Sub-continent

12:30 - 4:00 Thyroid Nodule and Thyroid

Cancer Primer

2:00 - 4:00 AHNS Endocrine Section Program

4:00 - 6:00 pm International Association of

Endocrine Surgery Symposium

12:00 -2:00

LUNCH /Exhibit Hall

Meet the Professors

1 - 9

ePosters

12:30 – 1:15 Hot Topic 1

One Size Does Not Fit All

12:00 -2:00

LUNCH /Exhibit Hall

Meet the Professors

10-18

ePosters

12:15 - 1:15 Hot Topic 2

Radiology vs. Endocrine vs.

Surgery

12:00 Closing Remarks

12:15



14:00

14:10 2:10 - 3:30 Panel 3

Instructional Courses 1 - 7

2:10 - 3:30 Panel 7

Oral Papers - 9 & 10

MTP 7b

IC 6b

2:00 - 3:00 Thyroid Cancer

Bioethics

2:00 – 3:05 pmVideo Session 2

15:30 3:30 - 4:00 BREAK / Exhibit Hall

3:30 - 4:00 BREAK / Exhibit Hall



16:30 4:30 - 6:00 Panel 4

Instructional Courses 8 - 14

4:30 - 6:00Instructional Courses 15 - 21

18:00 6:00 – 7:30 pm Video Session 1

6:00 – 8:00 pm CONGRESS RECEPTION

6:00 – 7:05 pm Video Session 3

19:00 7:00 pmDinner Symposium

Sponsored by Medtronic (No CME)

19:30 7:30 - 10:00

CONGRESS BANQUET

All Breaks, Lunch, ePosters , Product Theater, Exhibits Are in the GalleriaFor meeting rooms, refer to the Daily Program


THURSDAY, JULY 27, 2017TIME SESSION LOCATION

8:00 am – 4:35 pm

EXPORTED ACS THYROID, PARATHYROID AND NECK ULTRASOUND COURSECourse Director: Russell SmithCo–Directors: Kevin Brumund and Barbra Miller

Commonwealth, Concourse Level

(Harborwing)

8:00 am – 5:00 pm

ROBERT SOFFERMAN, MD – MEMORIAL ADVANCED THYROID ULTRASOUND COURSE Course Director: Russell SmithCo–Directors: Anil Ahuja, William Faquin and Susan Mandel

Marina Ballroom, Lobby level

2:00 pm – 4:00 pm

AHNS ENDOCRINE SECTION PROGRAM Session Chair: David Terris

Webster Room, Lobby level

12:00 pm – 3:00 pm

LATIN AMERICA SYMPOSIUM Chair: Miguel Herrera

Carlton Conference Level

(Harborwing)

12:00 pm – 3:00 pm

ASIA–PACIFIC SYMPOSIUM Co–Chairs: Kyung Tae and Che–Wei Wu

Stone Room, Lobby level

12:00 pm – 3:00 pm

INDIAN SUB–CONTINENT SYMPOSIUM Chair: Madan Kapre

Hancock Room, Lobby level

12:30 pm – 4:00 pm

THYROID NODULE AND THYROID CANCER PRIMER Chair: Joe Scharpf and Catherine Sinclair

Burroughs Room, Conference level

(Harborwing)

4:00 pm – 6:00 pm

IAES SYMPOSIUMCourse Chairs: Gerard Doherty and Dimitrios Linos

Burroughs Room, Conference level

(Harborwing)

7:00 pmDINNER SYMPOSIUM (No CME) Why and How I Use Nerve Monitoring : Perspectives from Around the WorldSponsored by Medtronic

Marina Ballroom

PRE–CONFERENCEDay at a Glance

15

FRIDAY JULY 28, 2017TIME SESSION/Speaker LOCATION

7:00 am – 5:00 pm REGISTRATION OPEN Grand Ballroom Foyer,

Concourse Level

6:00 am – 7:30 am

BREAKFAST SYMPOSIUM (No CME) Diagnosis & Management of Advanced Thyroid Cancer Sponsored by Eisai

Marina Ballroom

7:00 am – 8:00 am COFFEE, TEA & JUICE will be served Grand Ballroom Foyer

7:40 am – 8:00 am WELCOME REMARKS Grand Ballroom

8:00 am – 9:30 am

PANEL 1 Evaluation and Management of Thyroid Nodules: Integrating Imaging, Cytology and Molecular Markers Moderator: Bryan McIverPanelists: Erik Alexander, Steve Hodak, Susan Mandel, Yuri Nikiforov, David Steward

Grand Ballroom

8:00 am – 9:30 am ORAL PAPER – 1 & 2 Lewis –Oral 1

Burroughs–Oral 2

9:30 am – 10:00 am

KEYNOTE LECTURE 1 The Genetic Landscape of Thyroid Cancer 2017 Dr. James Fagin, Memorial Sloan Kettering Cancer Center, New York, NY

Grand Ballroom

10:00 am – 10:30 am BREAK – Exhibit Hall and ePoster Sessions Galleria

10:00 am – 4:00 pm EXHIBIT HALL AND ePOSTER SESSIONS OPEN Galleria

10:30 am – 12:00 pm

PANEL 2 Management of Low–Risk Thyroid Cancer Moderator: Jatin ShahPanelists: Louise Davies, Bryan Haugen, Quan–Yang Duh, Doug Ross

Grand Ballroom

10:30 am – 12:00 pm ORAL PAPER – 3 & 4 Lewis –Oral 3

Burroughs–Oral 4

12:00 pm – 1:30 pm ePOSTER SESSIONS Galleria

12:00 pm – 2:00 pm LUNCH – EXHIBIT HALL Galleria

12:00 pm – 1:30 pm

MEET THE PROFESSORS (interactive)

1 – Stump the Endocrinologist/ Stump the Surgeon Commonwealth AB

2 – Thyroid Cancer Histology: Recognizing clinically important histologic subtypes Commonwealth C

3 – Update on Systemic Therapy Clinical Trials Stone

4 – Techniques and Tips in Avoiding Complications in Thyroid Surgery Webster

5 – RAI Ablation: Appropriate selection of patients and administered activities Marina Ballroom

6 – Is Prophylactic Level VI Neck Dissection Necessary? Carlton

7a– Strategies for Detection of Recurrent Disease in Long–Term Follow–up Griffin

8 – Minimally Invasive Surgery in Thyroid Cancer: Which patients, what approach? Lewis

9 – Staged Thyroidectomy, IONM and Decision Making Burroughs

12:15 pm – 1:15 pm

HOT TOPIC 1 One Size Does Not Fit All: Selecting Tumors for Active Surveillance or Less Aggressive Surgery Moderator: Peter Angelos Panelists: Michael Tuttle, Brendan Stack

Grand Ballroom

12:30 pm – 1:30 pm

SANOFI GENZYME PRODUCT THEATER (No CME)Medullary Thyroid Cancer: A Multidisciplinary Approach to TreatmentSpeaker: Bryan McIver

Galleria

CONFERENCEDay at a Glance


FRIDAY JULY 28, 2017TIME SESSION/Speaker LOCATION

1:30 pm – 2:00 pm

KEYNOTE LECTURE 2 Surgery for Primary Thyroid Cancer and its Recurrence Dr. Jeremy Freeman, University of Toronto, Toronto, ON

Grand Ballroom

2:10 pm – 3:30 pm

PANEL 3 Assessment and Management of Lymph Node Metastases in Thyroid Cancer: Radiographic mapping, pcnd, plnd, RF–Etoh options Moderator: Gregory RandolphPanelists: Geoffrey Thompson, Lisa Orloff, Gerard Doherty, Robert Levine

Grand Ballroom

2:10 pm – 3:30 pm

INSTRUCTIONAL COURSES

1 – Thyroid Cancer Guidelines Around the World Commonwealth AB

2 – ATA Guidelines on Surgical Management of Thyroid Cancer: Thyroid and nodes Commonwealth C

3 – The Preop Evaluation for Thyroid Cancer Stone

4 – Radiation Induced Thyroid Cancer: From Chernobyl to Fukishima Webster

5 – Management of Central Neck Dissection: Elective, therapeutic and recurrent (including non–surgical) Carlton

6a – Evaluation and Management of Recurrent Thyroid Cancer Griffin

7 – Update on Clinical Trials TKI Precision Oncology and Beyond Lewis

17a – Differentiated Thyroid Cancer: Long-term follow-up after initial therapy – Which tests? How often? How long?

Burroughs

3:30 pm– 4:00 pm BREAK – Exhibit Hall and ePoster Sessions Galleria

4:00 pm – 4:30 pm

KEYNOTE LECTURE 3 Surveillance and Management of Persistent or Recurrent Thyroid Cancer Dr. Bryan Haugen, University of Colorado, Aurora, CO

Grand Ballroom

4:30 pm – 6:00 pm

PANEL 4 Medullary Thyroid Cancer Moderator: Rossella EliseiPanelists: Jeff Moley, Steve Waguespack, Jeremy Freeman, Rich Wong

Grand Ballroom


4:30 pm – 6:00 pm

8 – RLN and SLN Intraoperative Management and Monitoring: Standards for high quality monitoring Commonwealth AB

9 – Micropapillary Thyroid Cancer: Observe or Treat Commonwealth C

10 – Techniques and Tips in Avoiding Complications in Thyroid Surgery Stone

11 – Diagnostic and Predictive Uses of Molecular Analysis in Thyroid Nodules and Thyroid Cancer Webster

12 – Office US in differentiated Thyroid Cancer: Pre–operative staging and post–operative follow–up Carlton

13 – Robotic Surgery and Minimally Invasive Approaches: Technique and patient selection and their global differences

Griffin

14 – Techniques and Tips for Achieving a Safe and Effective Revision Surgery for Recurrent/Persistent Neck Disease

Lewis

6:00 pm – 7:30 pm

VIDEO SESSION 1 Moderator: Jeremy FreemanReviewers: Gerard Doherty, Dan Fliss, Teresa Kroeker, Michael Odell and Jatin Shah

Marina Ballroom

6:00 pm – 8:00 pm CONGRESS RECEPTION IN EXHIBIT HALL Galleria

6:30 pm – 7:30 pm

STRYKER PRODUCT THEATER Recurrent Laryngeal Nerve Monitoring as a Standard of Care – standards, technology, and implementation (No CME)Speaker: Christoph Ulmer

Galleria

Day at a Glance

17

SATURDAY JULY 29, 2017TIME SESSION/Speaker LOCATION

7:00 am – 5:00 pm REGISTRATION OPEN Grand Ballroom Foyer,

Concourse Level

6:00 am – 7:30 am

BREAKFAST SYMPOSIUM (No CME) Importance of a Personalized Approach in the Risk Stratification of Patients with DTC Sponsored by Sanofi Genzyme

Marina Ballroom



8:00 am – 9:30 am ORAL PAPERS – 5 & 6 Lewis –Oral 5

Burroughs–Oral 6

8:00 am – 9:30 am

PANEL 5 Radioactive Iodine Therapy and Redifferentiation Therapy for Thyroid Cancer: Who, Why, When and How? Moderator: Michael TuttlePanelists: Megan Haymart, Doug Van Nostrand, Ujjal Malick

Grand Ballroom

9:30 am – 10:00 am

KEYNOTE LECTURE 4 The legacy of Theodor Kocher Dr. Peter Kopp, Northwestern University Feinberg School of Medicine, Chicago, IL

Grand Ballroom

10:00 am – 10:30 am BREAK – Exhibit Hall and ePoster Sessions Galleria

10:00 am – 4:00 pm EXHIBIT HALL AND ePOSTER SESSIONS OPEN Galleria

10:30 am – 12:00 pm ORAL PAPERS – 7 & 8 Lewis –Oral 7

Burroughs–Oral 8

10:30 am – 12:00 pm

PANEL 6 Management of Invasive Thyroid Cancer Moderator: Mark UrkenPanelists: Amy Chen, James Brierley, Dana Hartl, Henning Dralle, Joe Scharpf

Grand Ballroom

12:00 pm – 1:30 pm ePOSTER SESSIONS Galleria

12:00 pm – 2:00 pm LUNCH – EXHIBIT HALL Galleria

12:00 pm – 1:30 pm

MEET THE PROFESSORS (interactive)

10 – RAI Ablation: Preparation and dose selection Commonwealth AB

11 – Thyroid Cancer Case Presentations: Difficult management issues, World Congress Tumor Board Commonwealth C

12 – Bethesda FNA Classification and Molecular Testing/Thyroid Cytopathology Stone

13 – Imaging in Thyroid Cancer Beyond the Ultrasound: Pearls and pitfalls in application to clinical practice (US, CT, dopa, 124I, FDG PET, SPECT/CT) Webster

14 – Interventional Treatment of Distant Metastases: When should a patient be considered RAI refractory? Marina Ballroom

15 – Cytology Case Presentations: Challenging FNA’s (Conundrums and challenges in thyroid nodule workup) Carlton

16 – Web–Based Approaches to Facilitating Multidisciplinary Management in Community–Based Practices Griffin

17 – FNA Molecular Analysis Lewis

18 – Anaplastic Thyroid Cancer: Optimal approach to initial management Burroughs

12:15pm – 1:15 pm

HOT TOPIC 2 Radiology vs. Endocrine Vs. Surgery guidelines Moderator: Jeremy FreemanPanelists: Mary Frates, Bryan Haugen, Gregory Randolph, Marcin Barczynski, Yasuhiro Ito

Grand Ballroom

Day at a Glance


SATURDAY JULY 29, 2017TIME SESSION/Speaker LOCATION

12:30 pm – 1:30 pm

CBLPATH/UPMC EXPO THEATER Clinical Utility of ThyroSeq for Thyroid Nodules (No CME) Speakers: Yuri Nikiforov, Steven Hodak, Stephanie Lee, Kristen Otto

Galleria

1:30 pm –2:00 pm

KEYNOTE LECTURE 5 Adjuvant therapy for differentiated thyroid cancer Martin Schlumberger, Institute Gustav–Roussy, Villjuif

Grand Ballroom

2:00 pm – 3:00 pm THYROID CANCER BIOETHICS Speakers: Peter Angelos, Raymon Grogan, Sara Rosenthal Webster

2:00 pm – 3:00 pm

LEGALLY MINE PRODUCT THEATER Understanding Legal Tools: The Keys to Locking out Lawsuits and Lowering Taxes (No CME) This presentation is designed for Practicing US Physicians. Speaker: Art McOmbre

Galleria

2:00 pm – 3:05 pm

VIDEO SESSION 2 Moderator: Teresa KroekerReviewers: Jonathan Bernstein, Jonathan Clark, Raefe Gundelach and Nitin Pagedar

Marina Ballroom

2:10 pm – 3:30 pm

PANEL 7 Evaluation and Management of Poorly Differentiated, Anaplastic and Aggressive Variants of Thyroid Cancer Moderator: Ezra CohenPanelists: Robert Smallridge, Peter Sadow, Keith Bible, Marcia Brose, Richard Tsang, Robert Ferris, Mark Zafereo

Grand Ballroom

2:10 pm – 3:30 pm ORAL PAPERS – 9 & 10 Lewis –Oral 9

Burroughs–Oral 10

2:10 pm – 3:30 pm

MEET THE PROFESSORS (interactive)Commonwealth C

7b – Strategies for Detection of Recurrent Disease in Long-Term Follow-up

2:10 pm – 3:30 pm

INSTRUCTIONAL COURSEStone

6b – Evaluation and Management of Recurrent Thyroid Cancer

3:30 pm – 4:00 pm BREAK – Exhibit Hall and ePoster Sessions Galleria

4:00 pm – 4:30 pm

KEYNOTE LECTURE 6 Systemic Therapy for Metastatic Thyroid CancerDr. Lori Wirth, Massachusetts General Hospital, Boston, MA

Grand Ballroom

4:30 pm – 6:00 pm


15 – Management of the Airway in Locally Invasive Thyroid Cancer: When to Scrape, When to resect Commonwealth AB

16 – Initial Staging and Management of MTC (Basic Primer in Management of MTC) Commonwealth C

17b – Differentiated Thyroid Cancer: Long–term follow–up after initial therapy – Which tests? How often? How long? Stone

18 – Non Surgical Ablative Therapy for Thyroid Nodules and Cancer Interventional Webster

19 – The Increasing Incidence of Thyroid Cancer Carlton

20 – Parathyroid Preservation: State–of–the–Art Griffin

21 – Management of Pediatric Thyroid Cancer Lewis

6:00 pm – 7:05 pm

VIDEO SESSION 3 Moderator: Jeremy FreemanReviewers: Claudio Cernea, Manuel Durán, Nicholas McIvor, Daniel Rocke and Neil Tolley

Marina Ballroom

7:30 pm – 10:00 pm CONGRESS BANQUET Grand Ballroom

Day at a Glance

19

Day at a Glance

SUNDAY JULY 30, 2017

TIME SESSION/Speaker LOCATION

7:00 am–11:00 am REGISTRATION Grand Ballroom Foyer,

Concourse Level

6:00 am – 7:00 am

BREAKFAST SYMPOSIUM (No CME)The New Afirma Genomic Sequencing Classifier – Leveraging Enriched Genomic Data through RNA Sequencing and Advancements in Machine Learning to Identify More Benign Thyroid Nodules Sponsored by Veracyte

Marina Ballroom

6:00 am – 7:45 am

WCTC 5K RUN Sponsored by Sanofi Genzyme6:00 am – Shuttle buses begin running6:27 am – Welcome Remarks and Safety Briefing6:30 am – Start 5K Run & Walk6:45 am – Runners begin to finish6:57 am – First shuttle bus departs venue7:00 am – Walkers begin to finish7:45 am – Last shuttle bus departs venue

Bus ScheduleBus 1: Arrive at Westin Main Entrance: 5:15amDepart Westin: 5:30amDepart Hatch Shell for Westin: 7:10amBus 2: Arrive at Westin Main Entrance: 5:45amDepart Westin: 6:00amDepart Hatch Shell for Westin: 7:45am

Start at Hatch Shell



8:00 am – 9:30 am

PANEL 8 Systemic Therapy for Metastatic Thyroid Cancer Moderator: Keith BiblePanelists: Lori Wirth, Sophie Leboulleux, Matthew Ringel, Naifa Busaidy

Grand Ballroom

8:00 am – 9:30 am ORAL PAPERS – 11 & 12 Marina Ballroom – Oral 11

Commonwealth C – Oral 12

8:00 am – 9:30 am ORAL PAPERS – 13 & 14 Stone – Oral 13

Webster – Oral 14

9:30 am – 10:30 am

HOT TOPIC 3 NIFTP and Bethesda 2 Moderator: Bryan McIverPanelists: Edmund Cibas, Yuri Nikiforov

Grand Ballroom

10:30 am– 12:00 pm

CONVERSATION WITH THE MASTERS Moderator: Gregory RandolphPanelists: Bryan McIver, Bryan Haugen, Jeremy Freeman, Ezra Cohen, Jatin Shah, Ashok Shaha, Ian Witterick

Grand Ballroom

12:00 pm CLOSING REMARKS

WCTC 4 Boston 2021

WCTC 3.5 2019

(destination TBA)

Start planning now!


KEYNOTE SPEAKERS

Dr. James Fagin is Chief of the Endocrinology Service and a Member of the Human Oncology and Pathogenesis Program at MSKCC and a Professor of Medicine at Weill Medical College of Cornell University in New York City, N.Y. He specializes in the treatment of patients with thyroid cancer. His laboratory focuses on thyroid cancer genomics and on understanding the biology of these tumors, in order to identify specific therapies directed at key thyroid oncoproteins, and on understanding mechanisms of response and resistance to targeted therapies. He is a recipient of various awards, the Merck Prize of the European Thyroid Association, the Sidney H. Ingbar Distinguished Lectureship Award of the American Thyroid Association, the Clinical Endocrinology Trust Lectureship of the Society of Endocrinology in the UK and the Clinical Investigator Award of the Endocrine Society in 2014. He is also a past-president of the American Thyroid Association.

Dr. Jeremy Freeman attended medical school at the University of Toronto, graduating with highest honours. He completed his otolaryngology residency atthe University of Toronto. After receiving his Fellowship from the Royal College of Surgeons of Canada in 1978, he spent two further years of advanced training, one as a Gordon Richards Fellow at the Princess Margaret Hospital in Toronto in Radiation and Medical Oncology and a second year as a McLaughlin Fellow, training in Head and Neck Oncology at the Royal Marsden Hospital in London, UK. He was the first fellow of the Advanced Training Council sponsored by the two head and neck societies. He has delivered over 500 scholarly addresses and published 280 articles in the scientific literature. He is on the editorial board of several high impact journals. He has trained hundreds of post graduate residents and 71 fellows. A Full Professor, he occupies the Temmy Latner/Dynacare Chair in Head and Neck Oncology at the University of Toronto, Faculty of Medicine. He has an active practice focusing on head and neck oncology with a primary interest in endocrine surgery of the head and neck.

James Fagin

Jeremy Freeman

Keynote Sessions at a GlanceFRIDAY, JULY 28, 2017

TIME KEYNOTE SPEAKER

9:30am – 10:00am

Keynote Lecture 1 The Genetic Landscape of Thyroid Cancer 2017

Dr. James Fagin

1:30pm – 2:00pm

Keynote Lecture 2 Surgery for Primary Thyroid Cancer and its Recurrence

Dr. Jeremy Freeman

4:00pm – 4:30pm

Keynote Lecture 3 Surveillance and Management of Persistent or Recurrent Thyroid Cancer

Dr. Bryan Haugen

SATURDAY, JULY 29, 2017

9:30am – 10:00 am

Keynote Lecture 4 The legacy of Theodor Kocher

Dr. Peter Kopp

1:30pm – 2:00pm

Keynote Lecture 5 Adjuvant Therapy for Differentiated Thyroid Cancer

Prof. Martin Schlumberger

4:00pm – 4:30pm

Keynote Lecture 6 Systemic Therapy for Metastatic Thyroid Cancer

Dr. Lori Wirth

KEYNOTE SPEAKERS

GRAND BALLROOM

21

Bryan HaugenSince finishing training at the University of Colorado Health Sciences Center in 1993, Dr. Haugen has been interested in the molecular mechanisms governing thyrotrope function and thyroid neoplasms.

His current clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction and other endocrine tumors (parathyroid, adrenal, carcinoid). Dr Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets.

Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms. His research group is also actively studying novel regulation of the hypothalamic-pituitary-thyroid axis.

Dr. Peter Kopp is a Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine, and he has directed the Center for Genetic Medicine (CGM) at the Feinberg School of Medicine of Northwestern University in Chicago from 2007 to 2014. Dr. Kopp has extensive clinical experience in clinical endocrinology with a focus on thyroid cancer and thyroid dysfunction. His research is focusing on the molecular pathophysiology and genetics of thyroid and other endocrine disorders. Since 2013 he is the Editor-in-Chief of the journal Thyroid, an appointment that reflects his recognized expertise in clinical and basic thyroidology. Dr. Kopp is an author or co-author of more than 160 publications, including chapters in major textbooks such as Harrison’s Principles of Internal Medicine, Werner and Ingbar’s The Thyroid, and DeGroot and Jameson’s Endocrinology.

Martin Schlumberger is Professor of Oncology at University Paris-Sud. He chairs the Department of Nuclear Medicine and Endocrine Oncology at Gustave Roussy, Villejuif and the School for Cancer Sciences at University Paris-Sud. He is board certified in endocrinology, nuclear medicine and oncology.

He has published 335 original articles in English peer review journals, 80 revue articles, 60 chapters of books and two books. Since 2006, he is a member of the European and American expert taskforces that produced recommendations for the diagnosis and treatment of differentiated and medullary thyroid cancers.

« Centre Expert National pour les cancers de la thyroïde réfractaires » of the network for rare cancers of the French National Cancer Institute. He chairs the Endocrine Tumor Group of the EORTC.

Dr. Lori Wirth is Medical Director of Massachusetts General Hospital’s Center for Head and Neck Cancers and Associate Professor in Medicine at Harvard Medical School. Dr. Wirth received her BA from Brown University and MD from Columbia’s College of Physicians and Surgeons. She trained at New York Presbyterian Hospital and Dana-Farber/Harvard Cancer Center.

Dr. Wirth is an authority in advanced thyroid cancer and head and neck oncology, with expertise in new therapies for head and neck and thyroid cancers. Her research focuses on clinical trials and leveraging translational data to maximize the impact of trial outcomes.

In addition to overseeing the Center for Head and Neck Cancers, Dr. Wirth co-directs Mass General/Mass Eye and Ear’s Advanced Thyroid Cancer Clinic. Dr. Wirth is Chairperson of the International Thyroid Oncology Group, and sits on a number of national and international oncology committees, including NCCN’s Thyroid Committee

and ABIM’s Medical Oncology Exam Committee.

6/28/2017 Peter A. Kopp, MD - Northwestern Medicine - Google Maps

https://www.google.com/maps/contrib/101360760248674971196/photos/@41.8945043,-87.6217669,3a,75y,90t/data=!3m7!1e2!3m5!1s-rxOmoVdjuks%2FWA4-VuFu… 1/2

Image capture: Aug 2013 Images may be subject to copyright.

Peter A. Kopp, MD - Northwestern Medicine

0 contributions ›

REVIEWS PHOTOS

Peter A. Kopp, MD - Northwestern MedicinePeter Kopp

Martin Schlumberger

Lori Wirth


SPEAKERS:

Quan Y. Duh, MD, FACS: Nerve monitoring in the USA today

Gianlorenzo Dionigi, MD, FACS: Strict Protocol per INMSG recommendations vs. just turning it on

Hoon Yub Kim, MD, PhD, FACS: Nerve monitoring in Trans-Oral Robotic Thyroidectomy vs. Trans-cervical and any difference

Angkoon Anuwong, Police Major, MD, FRCST: Nerve monitoring in Trans-Oral Endoscopic Thyroidectomy vs. Trans-cervical and any difference

Henning Dralle, FRCS, FACS, FEBS: Nerve Monitoring in thyroid surgery: impact on surgical strategy and future directions

Friday, July 28th6:00 - 7:30 amBreakfast Symposium

Diagnosis & Management of Advanced Thyroid Cancer

MODERATOR: R. Michael Tuttle, M.D. (Memorial Sloan Kettering Cancer Center)

PANELISTS: Naifa Lamki Busaidy, M.D. (The University of Texas MD Anderson Cancer Center)Bryan Haugen, M.D. (University of Colorado School of Medicine)Matthew H. Taylor, M.D. (Oregon Health & Science University)Lori J. Wirth, M.D. (Massachusetts General Hospital)

Please join us for a panel discussion with thyroid experts covering the critical aspects of identifying, evaluating and managing patients with advanced thyroid cancer.

SPONSORED SYMPOSIA (NO CME) Thursday, July 27th7:00 pmDinner Symposium

Why and How I Use Nerve Monitoring : Perspectives from Around the World

MARINA BALLROOM

Sponsored by

Sponsored by

Vermont law prohibits, Minnesota law restricts, and Department of Veterans Affairs and Department of Defense policy prohibits Eisai from offering meals at speaker events to certain health care professionals. If you are licensed in either of those states, or employed by either agency, Eisai regrets that due to these restrictions, we will not be able to offer a meal in conjunction with this event. Additionally, Eisai is required by Massachusetts, Vermont and Washington, DC, law and the Federal Physician Payment Sunshine Act to disclose certain value transfers, e.g., meals or payments, provided to certain health care professionals. If you have any questions, please speak with an Eisai representative at the meeting.This invitation is intended for the recipient only. Spouses or other guests are not permitted to attend Speaker Programs. This promotional event is sponsored by Eisai, and the speaker is a paid consultant presenting on behalf of Eisai. Eisai complies with all relevant laws, regulations, and codes of conduct.

This symposium will cover different aspects and perspectives of thyroid surgery and thus provide many opportunities to learn more about the advancement of neuro-monitoring for protection of the laryngeal nerves.

WELCOMING REMARKS AND MONITORING COMMENTARY:

Gregory W. Randolph, MD, FACS, FACE Professor of Otolaryngology Head and Neck Surgery Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology, Harvard Medical School Director General and Thyroid/Parathyroid Endocrine Surgical Divisions Massachusetts Eye and Ear Infirmary President American Academy of Otolaryngology Head and Neck Surgery Member of INMSG Steering Committee Co-Chair of the World Congress on Thyroid Cancer

MODERATOR:

Ralph P. Tufano, MD, MBA, FACSCharles W. Cummings MD Endowed Professor American Thyroid Association Board of Directors Director of the Division of Head and Neck Endocrine SurgeryDepartment of Otolaryngology-Head and Neck SurgeryJohns Hopkins University School of Medicine

23

Saturday, July 29th6:00 - 7:30 amBreakfast Symposium

Importance of a Personalized Approach in the Risk Stratification of Patients with DTCCHAIR:

Steven Sherman

PANELISTS:

Jeremy Freeman, Leonard Wartofsky, Douglas Van Nostrand

2015 ATA guidelines have recommended an individualized approach to the management of patients with differentiated thyroid cancer. This strategy will help to assess response to initial treatment as well as guide disease surveillance and therapeutic management decision-making. Clinicians must decide whether to perform lobectomy, total thyroidectomy as well as lymph node dissection when appropriate. Pathology reports are key to informing disease status as are imaging studies using neck ultrasonography and/or 131I whole body scans. Thyroglobulin and stimulated thyroglobulin testing are also effective tools which can be employed. With objective information in hand, clinicians will be able to more confidently decide which patients can now be safely monitored and which may benefit from more surgery or radioactive iodine. The degree of available information, experience level of multidisciplinary team and patient preferences play an important role in the decision to treat and follow-up of DTC. Brief didactic presentations will illustrate the need for individualization followed by panel case discussions.

Sunday, July 30th6:00 - 7:30 amBreakfast Symposium Breakfast service beginning at 6:00 am. Presentations begin at 6:30 am

The New Afirma Genomic Sequencing Classifier – Leveraging Enriched Genomic Data through RNA Sequencing and Advancements in Machine Learning to Identify More Benign Thyroid Nodules

SPEAKERS:

Giulia C. Kennedy, Chief Scientific Officer and Senior Vice President of Research and Development, VeracyteRichard T. Kloos, Senior Medical Director, Endocrinology, Veracyte

This special presentation will provide an in-depth overview of Veracyte’s next-generation Afirma Genomic Sequencing Classifier (GSC). The event will cover the following learning objectives:

• Discuss scientific development of the Afirma GSC

• Review Afirma GSC validation results

• Illustrate impact of Afirma GSC’s improved test performance

– Increase benign results by >30% to further reduce unnecessary surgeries

– Increase prevalence of cancer in Afirma GSC Suspicious cases

Sponsored by

Sponsored by

MARINA BALLROOM


PANEL SESSIONS FRIDAY, JULY 28, 2017 Grand Ballroom

TIME PANEL MODERATOR PANALSTS

8:00 am – 9:30 am

PANEL 1 Evaluation and Management of Thyroid Nodules: Integrating Imaging, Cytology and Molecular Markers

Bryan McIver

Erik AlexanderSteven HodakSusan MandelYuri NikiforovDavid Steward

10:30 am – 12:00 pm

PANEL 2 Management of Low-Risk Thyroid Cancer

Jatin Shah

Louise DaviesQuan-Yang DuhBryan HaugenDoug Ross

12:30 pm – 1:15 pm

HOT TOPIC 1 One Size Does Not Fit All: Selecting Tumors for Active Surveillance or Less Aggressive Surgery

Peter Angelos Brendan StackMichael Tuttle

2:10 pm – 3:30 pm

PANEL 3 Assessment and Management of Lymph Node Metastases in Thyroid Cancer

Gregory Randolph

Gerard DohertyRobert LevineLisa OrloffGeoffrey Thompson

4:30 pm – 6:00 pm

PANEL 4 Medullary Thyroid Cancer

Rossella Elisei

Jeremy FreemanJeff MoleySteve WaguespackRich Wong

SATURDAY, JULY 29 , 2017 Grand Ballroom

8:0O am – 9:30 am

PANEL 5 Radioactive Iodine Therapy and Redifferentiation Therapy for Thyroid Cancer: Who, Why, When and How?

Michael TuttleMegan HaymartUjjal MallickDoug Van Nostrand

10:30 am – 12:00 pm

PANEL 6Management of Invasive Thyroid Cancer

Mark Urken

James BrierleyAmy ChenHenning DralleDana HartlJoe Scharpf

12:15 pm – 1:15 pm

HOT TOPIC 2 Radiology vs. Endocrine vs. Surgery guidelines

Bryan Haugen

Marcin BarczynskiMary FratesJeremy FreemanYasuhiro ItoGregory Randolph

2:10 pm – 3:30 pm

PANEL 7Evaluation and Management of Poorly Differentiated, Anaplastic and Aggressive Variants of Thyroid Cancer

Ezra Cohen

Keith BibleMarcia BroseRobert FerrisPeter SadowRobert SmallridgeRichard TsangMark Zafereo

SUNDAY, JULY 30, 2017 Grand Ballroom

8:00 am – 9:30 am

PANEL 8 Systemic Therapy for Metastatic Thyroid Cancer

Keith Bible

Naifa BusaidySophie LeboulleuxMatthew RingelLori Wirth

9:30 am – 10:30 am

HOT TOPIC 3 NIFTP and Bethesda 2

Bryan McIver Edmund CibasYuri Nikiforov

10:30 am– 12:00 pm

CONVERSATION WITH THE MASTERSManagement of Complications

Gregory Randolph

Ezra CohenJeremy FreemanBryan HaugenBryan McIverJatin ShahAshok ShahaIan Witterick

GRAND BALLROOM

25

FRIDAY, JULY 28 12:00 PM – 1:30 PM

FACULTY COURSE & CONTENT ROOM Moderator: Jeremy FreemanStephanie LeeNikolas StathatosPablo ValderrabanoIan Witterick

1 Stump the Endocrinologist/ Stump the Surgeon Moderator will present the case and elicit audience response, followed by comments from the professors

Commonwealth AB (Concourse Level)

Moderator: Ronald GhosseinVirginia LivolsiRicardo LloydYuri NikiforovVânia NoséBruce Wenig

2 Thyroid Cancer Histology: Recognizing Clinically Important Histologic Subtypes Slide review session demonstrating examples and tips for diagnosing important histologic subtypes including: FTC, minimally invasive FTC, encapsulated FVPTC/NIFTP, tall cell variants, insular, poorly differentiated and anaplastic cancer.

Commonwealth C (Concourse Level)

Moderator: Ezra CohenMarcia BroseSaad KhanSophie LeboulleuxJohannes Smit

3 Update on Systemic Therapy Clinical Trials Review of ongoing or recently completed clinical trials in medullary, well differentiated, and anaplastic cancer.

Stone (Lobby Level)

Moderator: Quan-Yang DuhGaurav AgarwalDennis KrausKyung TaeMark Varvares

4 Techniques and Tips in Avoiding Complications in Thyroid Surgery An overview of neural and parathyroid complications: avoidance, early detection and appropriate treatment.

Webster (Lobby Level)

Moderator: Mona SabraRossella EliseiJeff GarberMarkus LusterElizabeth Pearce

5 RAI Ablation: Appropriate selection of patients and administered activities Discuss proper selection of patients for ablation, and what doses should be used in light of the new studies confirming 30 mCi effectiveness in low risk patients.

Marina Ballroom (Lobby Level)

Moderator: Gerard DohertyAmit AgarwalIan GanlyEmad KandilLisa Orloff

6 Is Prophylactic Level VI Neck Dissection Necessary? What is a level VI dissection? What are the risks and benefits? Which patients should be selected for routine prophylactic neck dissection?

Carlton (Harborwing – Conference Level)

Moderator: Leonard WartofskyLaura BoucaiJames HennesseySebastiano Filetti

7a Strategies for Detection of Recurrent Disease in Long-Term Follow-up Discuss a rationale approach to follow up thyroid cancer patients that includes a strategy for the first 1-2 years, and a strategy for long term follow up.

Griffin (Harborwing – Conference Level)

Moderator: David TerrisSteve LibuttiCelestino LombardiPaolo MiccoliAkira MiyauchiErivelto Volpi

8 Minimally Invasive Surgery in Thyroid Cancer: Which patients, what approach? Proper patient selection, and discussion of the various techniques.

Lewis (Harborwing - Conference Level)

Moderator: Gregory RandolphMarcin BarczynskiHenning DralleOliver GimmPeter Goretski

9 Staged Thyroidectomy, IONM and Decision Making Bilateral surgery and staging.

Burroughs (Harborwing – Conference Level)

MEET THE PROFESSOR


SATURDAY, JULY 2912:00 PM – 1:30 PM

FACULTY COURSE & CONTENT ROOM Moderator: Megan HaymartAnca AvramCS BalJeremy Freeman

10 RAI Ablation: Preparation and dose selection Practical clinical discussion of the required preparation (method of TSH stimulation, rhTSH vs short term LT4 withdrawal, +/- T3 bridge, low iodine diet) and which administered activity should be used.

Commonwealth AB (Concourse Level)

Moderator: Michael TuttlePeter Angelos Wendy Sacks David Terris

11 Thyroid Cancer Case Presentations: Difficult management issues, World Congress Tumor Board Presentation of several cases with difficult management issues (primarily surgical based): Small volume LN recurrence, gross extrathyroidal extension at presentation, etc.

Commonwealth C (Concourse Level)

Moderator: Edmund CibasErik AlexanderWilliam FaquinChristina Macmillan

12 Bethesda FNA Classification and Molecular Testing/Thyroid Cytopathology Now that the FNA Classification System has been around for a few years, this session will discuss whether or not it has been helpful and clinically useful and what modifications should be considered to make it better.

Stone (Lobby Level)

Moderator:Stephanie LeeLaurie LoevnerEllen MarquseeDavid StewardEugene Yu

13 Imaging in Thyroid Cancer Beyond the Ultrasound: Pearls and pitfalls in application to clinical practice (US, CT, dopa, 124I, FDG PET, SPECT/CT) Discuss the proper use of FDG PET and the newer PET isotopes (DOPA< 124I), as well as the role of SPECT CT in RAI scanning and therapy.


Moderator: Stefanie FishNaifa BusaidyRavinder Grewal Yariv HouvrasJochen Lorch

14 Interventional Treatment of Distant Metastases: When should a patient be considered RAI refractory? Discuss when to stop giving RAI in patients with distant mets.

Marina Ballroom (Lobby Level)

Moderator: Zubair BalochGuido FaddaSusan Mandel

15 Cytology Case Presentations: Challenging FNA’s (Conundrums and challenges in thyroid nodule workup) Using a case based approach discuss cases that demonstrate difficult FNA decision making.

Carlton (Conference Level)

Moderator: Mark UrkenMark Lupo

16 Web-Based Approaches to Facilitating Multidisciplinary Management in Community-Based Practices Discuss the role of the Internet in the management of thyroid cancer including Global quality registers and Thyroid cancer care collaborative: multidisciplinary management in the community.

Griffin (Conference Level)

Moderator: Bryan McIverGiulia KennedySareh Parangi Julie Ann SosaRobert Witt

17 FNA Molecular Analysis Current applications for mutation testing in pre-op FNA evaluation.

Lewis (Conference Level)

Moderator: Robert SmallridgeKeith BibleDerrick LinJoe ScharpfIwao SugitaniRichard Tsang

18 Anaplastic Thyroid Cancer: Optimal approach to initial management A discussion of treatment goals , recommended cumulative treatment levels and treatment toxicity. Clear clinical recommendations will be provided outlying scenarios where RAI treatment may be discontinued.

Burroughs (Harborwing –

Conference Level)

2:10 PM – 3:30 PMModerator: Leonard WartofskyJames HennesseyDouglas VanNostrandJatin Shah

7b Strategies for Detection of Recurrent Disease in Long-Term Follow-up Discuss a rationale approach to follow up thyroid cancer patients that includes a strategy for the first 1-2 years, and a strategy for long term follow up.

Commonwealth C (Concourse level)

27

FRIDAY, JULY 28, 2017 2:10 PM – 3:30 PMFACULTY COURSE & CONTENT ROOM

Moderator: Bryan Haugen Hernán GonzálezEleanora MolinaroKate NewboldTakahiro OkamotoFabian PitoiaDavid Scott-CoombesHiroshi Takami

1 Thyroid Cancer Guidelines Around the World A discussion of the similarities and differences between ATA/ NCCN/ British/ European and Japanese guidelines.

Commonwealth AB

Moderator: David StewardVictor BernetQuan-Yang DuhRichard PayneRalph Tufano

2 ATA Guidelines on Surgical Management of Thyroid Cancer: Thyroid and nodes Indications and extent for thyroid and nodal surgery. Central and lateral neck dissections in papillary, including what to do with LNs found on pre-op US before the initial thyroidectomy.

Commonwealth C

Moderator: Amy ChenMiguel HerreraMona SabraCatherine SinclairRich Wong

3 The Preop Evaluation for Thyroid Cancer Pre-operative evaluation of thyroid cancer: risk factors, invasive disease assessment, FNA, laryngoscopy, pre-op US, nodal map and other imaging.

Stone (Lobby Level)

Moderator: Geraldine ThomasDaniel BranovanShin-ichi SuzukiPat Zanzonico

4 Radiation Induced Thyroid Cancer: From Chernobyl to Fukishima Review of events leading to the releases from the reactors, the radio-protective measures put in place, and anticipated medical consequences.


Moderator: Jeremy FreemanJonathan ClarkGianlorenzo DionigiYasuhiro ItoMartha Zeiger

5 Management of Central Neck Dissection: Elective, therapeutic and recurrent (including non-surgical) Central neck management: therapeutic techniques and indications for prophylactic as well as recurrent central neck disease management.


Moderator: Ken BurmanCosimo DuranteBeth Edeiken-MonroeAnna SawkaRicard SimoRussell SmithNikolas Stathatos

6a Evaluation and Management of Recurrent Thyroid Cancer Follow up paradigms and management for recurrent differentiated thyroid cancer.


Moderator: Lori WirthMaria CabanillasErza CohenYariv HouvrasMartin Schlumberger

7 Update on Clinical Trials TKI Precision Oncology and Beyond Modern review of chemotherapeutic options and clinical trials for advanced thyroid cancer. Focused, precise and personalized oncologic treatment for advanced thyroid cancer.

Lewis (Harborwing – Conference Level)

Moderator: Wendy SacksKen AinStephanie FishDan Fliss

17a Differentiated Thyroid Cancer: Long-term follow-up after initial therapy – Which tests? How often? How long? Review the proper follow up of DTC patients after thyroidectomy: US, Suppressed Tg, stim Tg, other cross sectional imaging. How does this evaluation change over time?

Burroughs (Conference Level)



FRIDAY, JULY 28, 2017 4:30 PM – 6:00 PMFACULTY COURSE & CONTENT ROOM

Moderator: Greg RandolphMarcin Barczynski

Claudio Cernea

Gianlorenzo Dionigi

Erivelto Volpi

Che-Wei Wu

8 RLN and SLN intraoperative management and monitoring: standards for accurate neural monitoring The pros and cons of nerve monitoring, pearls and pitfalls.

Commonwealth AB

Moderator: Mike TuttleLouise DaviesLeslie EldeiryRobert LevineDoug RossPeter Sadow

9 Micropapillary Thyroid Cancer: Observe or Treat Incidence of papillary micro CA, should it really be called papillary microtumor, practical management issues.

Commonwealth C

Moderator: Peter AngelosRichard HodinTeresa KroekerPhilip PelliterriAntonia Stephen

10 Techniques and Tips in Avoiding Complications in Thyroid Surgery Techniques and tips for preserving parathyroid glands, RLN, superior laryngeal nerve and avoiding hematomas, etc.

Stone (Lobby Level)

Moderator: Matthew RingelGilbert CoteTom FaheyYuri NikiforovKepal PatelMingzhao Xing

11 Diagnostic and Predictive Uses of Molecular Analysis in Thyroid Nodules and Thyroid Cancer State-of-the-art molecular analysis for preoperative evaluation FNA.


Moderator: Susan MandelErik AlexanderMark LupoCarmen Solarzano

12 Office US in differentiated Thyroid Cancer: Pre-operative staging and post-operative follow-up Preoprative evaluation of cervical LN – which LNs need FNA prior to initial surgery? Postoperative follow-up US after initial therapy, concentrating on detecting recurrent disease.


Moderator: Emad Kandil Woong Youn ChungYoon Woo KohAkira MiyauchiHyun SuhDavid TerrisNeil Tolley

13 Robotic Surgery and Minimally Invasive Approaches: Technique and patient selection and their global differences Robotic and Endoscopic surgery: indications, techniques and applications.


Moderator: Ashok ShahaGary ClaymanMete DürenDan FlissCarsten Palme

14 Techniques and Tips for Achieving a Safe and Effective Revision Surgery for Recurrent/Persistent Neck Disease Surgical techniques and tips that maximize removal of persistent disease while minimizing complications.


Instructional Courses

29

Instructional Courses

SATURDAY, JULY 29, 2017 2:10 PM – 3:30 PMMODERATOR SPEAKERS COURSE & CONTENTKen Burman Cosimo DuranteBeth Edeiken-MonroeAnna SawkaRicard Simo

6b Evaluation and Management of Recurrent Thyroid Cancer Follow up paradigms and management for differentiated thyroid cancer.

Stone (Lobby Level)

SATURDAY, JULY 29, 2017 4:30 PM – 6:00 PMMODERATOR SPEAKERS COURSE & CONTENTModerator: Dana HartlJames BrierleyJonathan ClarkRalph GilbertGuri SandhuIwao Sugitani

15 Management of the Airway in Locally Invasive Thyroid Cancer: When to Scrape, When to resect Surgical management of thyroid cancer adherent to, or invading the airway.

Commonwealth AB

Moderator: Rich WongElizabeth GrubbsPatrick GullaneJonathan IrishJeff Moley

16 Initial Staging and Management of MTC (Basic Primer in Management of MTC) Focus on medullary thyroid cancer and the extent of staging based on pre-op calcitonin/CEA. What should be the initial thyroid surgery and the initial lymph node dissection? What about EBRT in patients with extensive LN involvement.

Commonwealth C

Moderator: Wendy SacksKen AinStephanie FishDan FlissMack HarrellMatt Kim

17b Differentiated Thyroid Cancer: Long-term follow-up after initial therapy – Which tests? How often? How long? Review the proper follow up of DTC patients after thyroidectomy: US, Suppressed Tg, stim Tg, other cross sectional imaging. How does this evaluation change over time?

Stone (Lobby Level)

Moderator: Jung Hwan BaekDaniele BarbaroAndrea FrasoldatiNobuhiro FukunariIan HayTara Henrichsen

18 Non Surgical Ablative Therapy for Thyroid Nodules and Cancer Interventional Alcohol and other ablative techniques for thyroid nodules and nodes.


Moderator: Luc MorrisAmy ChenLouise DaviesCarrie LubitzCatherine SinclairKyung Tae

19 The Increasing Incidence of Thyroid Cancer PTC world wide epidemic.


Moderator: Antonio Stiges- Serra Michele D’AgelloPieter NoordzijNancy PerrierNeil Tolley

20 Parathyroid Preservation: State-of-the-Art Thyroid surgery. Perioperative Calcium and discharge issues: parathyroid preservation, restoration and replacement.


Moderator: Andrew BauerGillian DiercksGeeta LalGeoffrey ThompsonSteve WaguespackDonald Zimmerman

21 Management of Pediatric Thyroid Cancer This session will review the Rx of thyroid cancer occurring in the pediatric age group including issues of initial Dx and workup through surgery and important questions of RAI and long term follow up for this thyroid cancer group



ORAL PAPER SESSIONS FRIDAY, JULY 28. 2017 ROOM

ORAL PAPER SESSIONS

8:00 am – 9:30 am

1 Thyroid Nodule Evaluation / OtherModerators: Jonathan George, Daniel Barbaro

LEWIS

8:00 am – 9:30 am

2 Differentiated Thyroid Cancer, Biomarkers and Basic ScienceModerators: Patrick Ha, Marika Russell

BURROUGHS

10:30 am – 12:00 pm

3 Medullary Thyroid Cancer / Anaplastic Thyroid Cancer / Innovative Technology

Moderators: Turid Aas, Zaid Al-QurayshiLEWIS

10:30 am – 12:00 pm

4 Complications of Thyroid Surgery/TreatmentMaria Albuja-Cruz, Laura Boucai

BURROUGHS

SATURDAY, JULY 29. 2017 ROOM

8:00 am – 9:30 am

5 Surgery of Thyroid or Lymph NodesModerators: Dev Kamdar, Innocent Kundiona

LEWIS

8:00 am – 9:30 am

6 Follow-up / Surveillance / Imaging, Radioiodine Therapy Moderators: Julie Hallanger-Johnson, Matt Magarey

BURROUGHS

10:30 am – 12:00 pm

7 Innovative Technology / Biomarkers and Basic SciencesModerators: Ellie Maghami, Michiya Nishino

LEWIS

10:30 am – 12:00 pm

8 Differentiated Thyroid CancerModerators: Marcia Brose, Nitin Pagedar

BURROUGHS

2:10 pm – 3:30 pm

9 Surgery of Thyroid or Lymph Nodes, Pediatric Thyroid Cancer, Quality of LifeModerators: Pamela Harzband, Kristen Otto

LEWIS

2:10 pm – 3:30 pm

10 Innovative TechnologyModerators: Dan Rocke, Ilana Doweck

BURROUGHS

SUNDAY, JULY 30. 2017 ROOM

8:00 am – 9:30 am

11 Thyroid Nodule EvaluationModerators: Johanna Palotta, David Cohen

MARINA BALLROOM

8:00 am – 9:30 am

12 Chemotherapy / TKI and Immunotherapy,Radiation Therapy, Radioiodine Therapy,Epidemiology, Etiology / PathologyModerators: Chris Macmillan, Madan Kapre

COMMONWEALTH C

8:00 am – 9:30 am

13 Preoperative Evaluation, Quality of LifeModerators: Peter Vosler, Ricard Simo

STONE

8:00 am – 9:30 am

14 Biomarkers and Basic Sciences, OtherModerators: Ilana Doweck, Saad Khan

WEBSTER

31

VIDEO SESSIONSVIDEO SESSION 1 FRIDAY, JULY 28, 2017 6:00 PM – 7:30 PM TIME MODERATOR REVIEWERS VIDEO & PRESENTER6:00 pm – 6:13 pm

Jeremy Freeman Gerard Doherty

Dan Fliss

Teresa Kroeker

Michael Odell

Jatin Shah

V1 Thyroidectomy – Jeremy Freeman

6:14 pm – 6:27 pm

V2 Thyroidectomy – Geoffrey Thompson

6:28 pm – 6:41 pm

V3 Comprehensive Lateral Neck Dissection – Jatin Shah

6:42 pm – 6:55 pm

V4 Reoperativecentral Neck Dissection – Matthew Magarey

6:56 pm – 7:09 pm

V5 Reoperativecentral Neck Dissection – Ralph Tufano

7:10 pm – 7:23 pm

V6 Tracheal Resection – Guri Sandhu

VIDEO SESSION 2 SATURDAY, JULY 29, 2017 2:00 PM – 3:05 PM

2:00 pm – 2:10 pm

Teresa Kroeker Jonathan Bernstein

Jonathan Clark

Raefe Gundelach

Nitin Pagedar

V7 Robot-Assisted Transaxillary Total Thyroidectomy for Graves’ Ophthalmopathy after Radio Active Iodine Ablation – Daniah Bu Ali

2:11 pm – 2:21 pm

V8 Transaxillary Robotic Total Thyroidectomy for Grave’s Disease – Patrick Aidan

2:22 pm – 2:32 pm

V9 Transaxillary Robotic Thyroidectomy: Delicate Nerve Dissection in a Papillary Carcinoma – Patrick Aidan

2:33 pm – 2:43 pm

V10 Upgraded Bidirectional Approach of Video-Assisted Neck Surgery (BAVANS) – Endoscopic Complete Lymph Node Dissection with Craniocaudal View for Treatment of Thyroid Cancer – Akihiro Nakajo

2:44 pm – 2:54 pm

V11 Papillary Thyroid Cancer with Synchronous Lymph Nodes Metastases: Left Lateral Neck Dissection and Total Thyroidectomy With Continuous Intraoperative Nerve Monitoring – Maria Grazia Chiofalo

2:55 pm – 3:05 pm

V12 Transoral Endoscopic Thyroidectomy with Standardized Neural Monitoring: Technique – Gianlorenzo Dionigi

VIDEO SESSION 3 SATURDAY, JULY 29, 2017 6:00 – 7:05 PM

6:00 pm – 6:10 pm

Jeremy Freeman Claudio Cernea,

Manuel Durán

Nicholas McIvor

Daniel Rocke

Neil Tolley

V13 Segmental tracheal resection with end-to-end anastomosis preserving membranous portion for patients with thyroid carcinoma – Toyone Kikumori

6:11 pm – 6:21 pm

V14 Head Mounted Video Camera 2013 – Andrea Ortensi

6:22 pm – 6:32 pm

V15 The Surgical Management of Advanced Thyroid Cancer Invaded with Neck Great Vessels – Keisuke Enomoto

6:33 pm – 6:43 pm

V16 Novel use of Continuous Vagus Stimulation in a Robotic Transaxillary Thyroidectomy – Khuzema Mohsin

6:44 pm – 6:54 pm

V17 Two useful adjuncts to thyroid oncological surgery: the ansa to recurrent nerve anastomosis and mediastinoscopy approach to metastatic disease– Peter Vosler

6:55 pm – 7:05 pm

V18 Two approaches to conservative neck dissection – Peter Vosler

MARINA BALLROOM


EXHIBIT HALL, GALLERIAePOSTERS

FRIDAY, JULY 28. 2017 12:00 PM – 1:30 PM EXHIBIT HALL, GALLERIA

SESSION 1 Anaplastic Thyroid Cancer Moderators: Yogesh Bhatt, Katrin Brauckhof

STATION 1

SESSION 2 Differentiated Thyroid Cancer Moderators: Gian-Marco Busato, Richard Payne

STATION 2

SESSION 3 Differentiated Thyroid Cancer Moderators: Estelle Chang, Prathamesh Pai

STATION 3

SESSION 4 Biomarkers and Basic Sciences Moderators: Luk Czerwonka, Fernando Luis Dias

STATION 4

SESSION 5 Etiology / Pathology, Epidemiology, Cytopathology, Other Moderators: José Miguel Dominguez, Manuel Durán

STATION 5

SESSION 6 Preoperative Evaluation Moderators: Christopher Fundakowski, Julie Goddard

STATION 6

SESSION 7 Thyroid Nodule Evaluation Moderators: Gregory Grillone, Raefe Gundelach

STATION 7

SESSION 8 Surgery of Thyroid or Lymph Nodes, Complications of Thyroid Surgery/ Treatment Moderators: Jon Russel, Kristen Otto

STATION 8

SATURDAY, JULY 29. 2017 12:00 PM – 1:30 PM EXHIBIT HALL, GALLERIA

SESSION 9 DIFFERENTIATED THYROID CANCER Moderators: Gaurav Agrawal

STATION 1

SESSION 10 Medullary Thyroid Cancer, Thyroid Nodule Evaluation Moderators: Ron Walker, Rich Wein

STATION 2

SESSION 11 Pediatric Thyroid Cancer, Other Moderators: Amanda Karcioglu, Kaustubh Patel

STATION 3

SESSION 12 Innovative Technology, Differentiated Thyroid Cancer Moderators: Aviram Mizrachi, Avi Hefetz

STATION 4

SESSION 13 Complications of Thyroid Surgery / Treatment Moderators: David Shonka, Julie Hallanger-Johnson

STATION 5

SESSION 14 Differentiated Thyroid Cancer Moderators: Elizabeth Cottrill, Innocent Kundiona

STATION 6

SESSION 15 Surgery of Thyroid or Lymph Nodes, Follow-up / Surveillance / Imaging, Other Moderators: Pablo Valderrabano, Dipti Kamani

STATION 7

SESSION 16 Chemotherapy / TKI and Immunotherapy, Radioiodine Therapy, Quality of Life Moderators: Michael Odell, Efrain Cambronero

STATION 8

33

NOTES


NOTES

thyroidworldcongress.com

For information including program descriptions, speaker bios, ePoster and Oral Paper sessions visit the World Congress on Thyroid Cancer website:

WCTC APPIncrease your engagement and don’t miss a thing! Download and stay up to date with programing and events: https://goo.gl/WLfNLJ

Password: WCTC2017

WCTC 4 Boston 2021

WCTC 3.5 2019

(destination TBA)

Start planning now!

PROGRAMthyroidworldcongress.com/.../2017/07/WCTC2017_Program-FINAL-PROOF.pdfappointed the Jay L....

Documents

Transcript of PROGRAMthyroidworldcongress.com/.../2017/07/WCTC2017_Program-FINAL-PROOF.pdfappointed the Jay L....